Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
VectivBio

VectivBio

Transforming Lives

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers

SEC Filings

Filing date Form Description Filing Group View
Nov 18, 2022 EFFECT

EFFECT

Other
9999999995-22-003342.pdf
9999999995-22-003342.rtf
9999999995-22-003342.xls
View HTML
Nov 16, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-286352.pdf
0001193125-22-286352.rtf
0001193125-22-286352.xls
View HTML
Nov 16, 2022 CORRESP

CORRESP

Other
0001193125-22-286748.pdf
0001193125-22-286748.rtf
0001193125-22-286748.xls
View HTML
Nov 10, 2022 F-3/A

Amendment to a previously filed F-3

Registration Statements
0001193125-22-282772.pdf
0001193125-22-282772.rtf
0001193125-22-282772.xls
View HTML
Oct 20, 2022 SC 13D/A

An amendment to a SC 13D filing

Other
0001104659-22-110186.pdf
0001104659-22-110186.rtf
View HTML
Oct 18, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-264187.pdf
0001193125-22-264187.rtf
0001193125-22-264187.xls
View HTML
Oct 14, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001193125-22-262921.pdf
0001193125-22-262921.rtf
0001193125-22-262921.xls
View HTML
Oct 13, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-261824.pdf
0001193125-22-261824.rtf
0001193125-22-261824.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Oct 13, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-261828.pdf
0001193125-22-261828.rtf
0001193125-22-261828.xls
View HTML
Sep 27, 2022 CORRESP

CORRESP

Other
0001836379-22-000019.pdf
0001836379-22-000019.rtf
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

Primary Sidebar

INVESTORS & MEDIA

  • Overview
  • News & Media
    • Press Releases
  • Events & Presentations
  • Annual General Meeting
  • Extraordinary General Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Stock Information
    • Historical Stock Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board Members
    • Committee Composition
  • Shareholder Resources
    • FAQs
    • Email Alerts
    • Contact IR
    • RSS Feeds

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

 

Footer

Site - Footer Menu Left

VectivBio

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2023. All Rights Reserved.

Site - Footer Menu Right

  • About Us
  • Our Focus
  • Investors & Media
  • Contact Us

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers